University Hospital Heidelberg
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Private
- Established
- 1388-01-01
- Employees
- -
- Market Cap
- -
iMDx Digital PCR Platform Shows Equivalent Performance to NGS in Kidney Transplant Rejection Testing
iMDx's digital PCR-based GraftAssureIQ test demonstrated equivalent donor-derived cell-free DNA measurements compared to next-generation sequencing platforms in a head-to-head study of 96 kidney transplant recipients.
Long-term Data Shows No Survival Advantage for Salvage Transplant vs. Lenalidomide in Relapsed Multiple Myeloma
Phase 3 GMMG ReLApsE trial reveals salvage transplantation plus lenalidomide/dexamethasone did not significantly improve survival compared to lenalidomide/dexamethasone alone in relapsed multiple myeloma patients.
HDP-101 Shows Promise in Relapsed/Refractory Multiple Myeloma
HDP-101, a novel BCMA-targeting antibody-drug conjugate, demonstrates encouraging efficacy in heavily pretreated multiple myeloma patients.